Tacrolimus ointment-induced relapse of schizophrenia: A case report

International Journal of Neuropsychopharmacology

Volumn 10, Issue 6, 2007, Pages 851-854

  Lin, Ying ^a   Sun, I Wen ^a,b   Liu, Shen Ing ^a,b   Loh, El Wui ^c   Lin, Yang Chih ^a,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Nursing   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d LEE MING INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; RISPERIDONE; TACROLIMUS;

ADULT; ATOPIC DERMATITIS; AUDITORY HALLUCINATION; CASE REPORT; CHINESE; DELUSION; DRUG DOSE REDUCTION; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; HUMAN; LETTER; MALE; OINTMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; RECURRENT DISEASE; RELAPSE; REMISSION; RIGIDITY; SCHIZOPHRENIA; SIDE EFFECT; SLEEP DISORDER;

ADULT; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TACROLIMUS;

EID: 35649018607     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707008024     Document Type: Letter

References (10)

1. Beck LA (2005). The efficacy and safety of tacrolimus ointment: a clinical review. Journal of the American Academy of Dermatology 53 (2 Suppl. 2), S165-170.
2. Beresford TP (2001). Neuropsychiatric complications of liver and other solid organ transplantation. Liver Transplantation 7 (11 Suppl. 1), S36-45.
3. Corruble E, Buhl C, Esposito D, Schuster JP, Chouinard VA, Hardy P, Chouinard G (2006). Psychosis associated with elevated trough tacrolimus blood concentrations after combined kidney-pancreas transplant. International Journal of Neuropsychopharmacology 9, 493-494.
4. Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF (2005). Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. Journal of the American Academy of Dermatology 53, 602-609.
5. Emiroglu R, Ayvaz I, Moray G, Karakayali H, Haberal M (2006). Tacrolimus-related neurologic and renal complications in liver transplantation: a single-center experience. Transplant Proceedings 38, 619-621.
6. Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proceedings of the National Academy of Sciences USA 100, 8993-8998.
7. Kaminska B, Gaweda-Walerych K, Zawadzka M (2004). Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. Journal of Cellular and Molecular Medicine 8, 45-58.
8. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003). Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proceedings of the National Academy of Sciences USA 100, 8987-8992.
9. Takao K, Miyakawa T (2006). Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice. Annals of the New York Academy of Sciences 1086, 144-159.
10. Teshima D, Ikesue H, Itoh Y, Urabe K, Furue M, Oishi R (2003). Increased topical tacrolimus absorption in generalized leukemic erythroderma. Annals of Pharmacotherapy 37, 1444-1447.